Trial · NCT00770484
Effect of Exercise in OI
NCT00770484, Not applicable, Completed, Vanderbilt University; results first posted 2015-07-09
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Exercise in OI. Trials, record NCT00770484. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00770484
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Exercise in OI
- NCT number
- NCT00770484
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 12 participants, actual
- Lead sponsor
- Vanderbilt University
- Conditions
- Orthostatic Intolerance, Postural Tachycardia Syndrome
- Interventions
- Propranolol then Placebo, Placebo then Propranolol
- First posted
- 2008-10-10
- Last updated
- 2016-08-05
- Results first posted
- 2015-07-09
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Maximal Oxygen Consumption Capacity (VO2 Max) | Over approximately 30 minutes, within 2 hours of receiving each intervention. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Maximal Oxygen Consumption Capacity (VO2 Max) | Over approximately 30 minutes, within 2 hours of receiving each intervention. | mL/kg/min | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximal Oxygen Consumption Capacity (VO2 Max) | Propranolol | 27.6 | Standard Error 1 | mL/kg/min | |
| Maximal Oxygen Consumption Capacity (VO2 Max) | Placebo | 24.5 | Standard Error 0.7 | mL/kg/min |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Propranolol Then Placebo | 8 | |
| Overall Study | STARTED | Placebo Then Propranolol | 4 | |
| Overall Study | COMPLETED | Propranolol Then Placebo | 7 | |
| Overall Study | COMPLETED | Placebo Then Propranolol | 4 | |
| Overall Study | NOT COMPLETED | Propranolol Then Placebo | 1 | |
| Overall Study | NOT COMPLETED | Placebo Then Propranolol | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Propranolol Then Placebo | ||
| Total, all-cause mortality | Placebo Then Propranolol | ||
| Total, other adverse events | Propranolol Then Placebo | 0 | 8 |
| Total, other adverse events | Placebo Then Propranolol | 0 | 4 |
| Total, serious adverse events | Propranolol Then Placebo | 0 | 8 |
| Total, serious adverse events | Placebo Then Propranolol | 0 | 4 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 23283362 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Propranolol Then Placebo vs Placebo Then Propranolol: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00770484
GET https://conductscience.org/api/trials/v1/NCT00770484/registered